Baird Upgrades Amedisys (AMED) to Neutral
Tweet
Share
E-mailGet Alerts AMED Hot Sheet
Price: $100.99 --0%
Rating Summary:
6 Buy, 15 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 27
Rating Summary:
6 Buy, 15 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 27
Join SI Premium – FREE
Baird upgraded Amedisys (NASDAQ: AMED) from Underperform to Neutral with a price target of $25.00.
For an analyst ratings summary and ratings history on Amedisys click here. For more ratings news on Amedisys click here.
Shares of Amedisys closed at $21.76 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Upgrades MarketAxess (MKTX) to Neutral
- Morgan Stanley Upgrades Towa Pharmaceutical Co Ltd (4553:JP) to Overweight
- Goldman Sachs Upgrades New Oriental Education & Technology Group (9901:HK) (EDU) to Buy
Create E-mail Alert Related Categories
UpgradesRelated Entities
Robert W BairdSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
